08:00 , Jan 4, 2010 |  BC Week In Review  |  Company News

Arigene, Trimeris deal

Arigene terminated its offer to acquire Trimeris at $3.60 per share, or about $82.1 million, after Arigene was unable to secure sufficient financing. The 86.4% of Trimeris shares that had been tendered as of the...
08:00 , Jan 4, 2010 |  BioCentury  |  Finance

VCs take over dalbavancin

Four years and three complete response letters after dalbavancin was brought into Pfizer Inc. (NYSE:PFE) as part of the pharma's $1.9 billion acquisition of Vicuron Pharmaceuticals Inc. , a group of VCs have spun the...
08:00 , Jan 4, 2010 |  BioCentury  |  Finance

Regulatory milestones

Arena Pharmaceuticals Inc. (NASDAQ:ARNA) was off $0.11 to $3.64 Christmas week after submitting an NDA to FDA for lorcaserin for weight management. Basilea Pharmaceutica AG (SIX:BSLN) fell CHF11.70 (15%) to CHF64.45 last Wednesday after FDA...
00:43 , Dec 30, 2009 |  BC Extra  |  Company News

Trimeris off after Arigene ends offer

Trimeris Inc. (NASDAQ:TRMS) fell $0.53 (17%) to $2.65 on Tuesday after Arigene Co. Ltd. (KOSDAQ:067850) terminated a tender offer to acquire the HIV company for $3.60 per share, or about $82.1 million. Arigene said it...
08:00 , Nov 23, 2009 |  BC Week In Review  |  Company News

Arigene, Trimeris deal

The companies agreed to extend to Dec. 28 from Nov. 16 the deadline for Arigene's tender offer for Trimeris. Arigene notified Trimeris earlier this month that Arigene would not have sufficient funds to complete its...
08:00 , Nov 23, 2009 |  BioCentury  |  Finance

Ebb & Flow

Last week's move by Bristol-Myers (NYSE:BMY) to split off its holdings in nutritional products play Mead Johnson (NYSE:MJN) is positioned as the final move in the company's grand plan to become solely focused on biopharmaceuticals....
02:11 , Nov 18, 2009 |  BC Extra  |  Company News

Arigene, Trimeris extend tender offer

Trimeris Inc . (NASDAQ:TRMS) and Arigene Co. Ltd. (KOSDAQ:067850) extended the deadline for Arigene's ongoing tender offer for Trimeris to Dec. 28 from Nov. 16. Last week, Arigene asked for an extension of the offer...
08:00 , Nov 16, 2009 |  BC Week In Review  |  Company News

Arigene, Trimeris deal

Trimeris received notice from Arigene that Arigene would not have sufficient funds to complete its ongoing tender offer for Trimeris by the Nov. 16 deadline. Arigene, which began the tender offer last month, asked for...
08:00 , Nov 16, 2009 |  BioCentury  |  Finance

Ebb & Flow

Although the terms of the acquisition of BioTrove Inc. by Life Technologies Corp. (NASDAQ:LIFE) haven't been undisclosed, the transaction could result in a more than 10X return over the next 12 months, according to investor...
00:27 , Nov 13, 2009 |  BC Extra  |  Company News

Trimeris falls as Arigene seeks extension

Trimeris Inc. (NASDAQ:TRMS) fell $0.64 (18%) to $2.95 on Thursday after receiving notice from Arigene Co. Ltd. (KOSDAQ:067850) that Arigene does not expect to have sufficient funds to complete its ongoing tender offer for Trimeris...